pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
396
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
AQ-002
Asthma
Aquilon Pharmaceuticals SA
Preclinical
AQ-003
Chronic Obstructive Pulmonary Disease (COPD)
Aquilon Pharmaceuticals SA
Preclinical
ARBM-201
Acute Respiratory Distress Syndrome
Arbormed Co Ltd
Phase 2
← prev
page 5 of 14
next →
131
Pain
89
Neurology
1
ARCT-032
Cystic Fibrosis
$ARCT
Arcturus Therapeutics Holdings Inc.
Preclinical
ATLX–0199
Unspecified Cardiovascular Disorders
Atelerix Life Sciences Inc
Phase 2
AV-0328
Streptococcal Pneumonia
Alopexx Inc
Preclinical
AVG-002
Unspecified Respiratory Disorders
AlveoGene Ltd
Phase 2
AZD-0292
Bronchiectasis
$AZN
ASTRAZENECA PLC
Phase 1
AZD-8965
Idiopathic Pulmonary Fibrosis
$AZN
ASTRAZENECA PLC
Preclinical
Anti-PD1 Antibody
Lymphangioleiomyomatosis
BioSputnik LLC
Preclinical
Antibody Drug Conjugate for Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Bionevix Ltd
Marketed
Augmentin
Augmentin ((amoxicillin + clavulanate potassium))
Skin And Skin Structure Infections (SSSI) Caused By Bacteria
NeoPharma Inc
Phase 2
BBT-877
Idiopathic Pulmonary Fibrosis
Parataxis Korea Inc
Phase 2
BI-1819479
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim International GmbH
Phase 1
BRS-101
Idiopathic Pulmonary Fibrosis
BreStem Therapeutics Inc
Phase 1
BSI-502
Atopic Dermatitis (Atopic Eczema)
$ACRS
Aclaris Therapeutics, Inc.
Marketed
Bicillin L A
Bicillin L A (penicillin G benzathine)
Upper Respiratory Tract Infections by Streptococcus pyogenes
$PFE
PFIZER INC
Phase 2
Broncho-Vaxom
Wheezing
OM Pharma Ltd
Preclinical
C-867
Asthma
Raesedo Inc
Preclinical
C-892
Asthma
Raesedo Inc
Phase 2
CAL-02
Community-Acquired Bacterial Pneumonia
Eagle Pharmaceuticals Inc
Phase 2
CAL-101
Idiopathic Pulmonary Fibrosis
Calluna Pharma AS
Preclinical
CBM-301
Idiopathic Pulmonary Fibrosis
CellionBioMed Inc
Preclinical
CEN-501
Allergic Rhinitis
NeuCen BioMed Co Ltd
Phase 2
CHF-6333
Bronchiectasis
Chiesi Farmaceutici SpA
Phase 1
CHF-6795
Chronic Cough
Chiesi Farmaceutici SpA
Preclinical
CIL-05
Primary Ciliary Dyskinesia
Cila Therapeutics Inc
Phase 2
CMTX-101
Pseudomonas aeruginosa Infections
Clarametyx Biosciences Inc
Preclinical
CTX-002
Coronavirus Disease 2019 (COVID-19) Associated Acute Resp…
Ceria Therapeutics Inc
Phase 2
CX-1739
Central Sleep Apnea
EndeavourRx LLC
